简介内容:VK-1727, a selective small molecule inhibitor of EBNA1, diminishes the DNA binding activity of EBNA1 and curtails the proliferation and metabolic activity of EBV+ cells while not affecting EBV- cells. This compound is utilized in research pertaining to multiple sclerosis [1].